Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Author： Morales Serafín   Lorenzo Antonio   Ramos Manuel   Ballesteros Pedro   Méndez Miguel   Almanza Concepción   Castellanos Javier   Moreno-Nogueira José   Casal Joaquín   Lizón José   Oltra Amparo   Frau Adolfo   Machengs Ignacio   Galán Antonio   Belón Joaquín   Llorca Cristina  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.1, 2004-01, pp. : 75-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

By Venturini M.   Bighin C.   Monfardini S.   Cappuzzo F.   Olmeo N.   Durando A.   Puglisi F.   Nicoletto O.   Lambiase A.   Mastro L.  

Breast Cancer Research and Treatment, Vol. 95, Iss. 1, 2006-01 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

By Papakostas P.   Kouroussis C.   Androulakis N.   Samelis G.   Aravantinos G.   Kalbakis K.   Sarra E.   Souglakos J.   Kakolyris S.   Georgoulias V.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1833-1838

Elsevier

Access to resources Recommend Favorite

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

By Idelevich Efraim   Karminsky Natalie   Dinerman Michael   Katsenelson Rivka L.   Zvi Nana Ben   Baruch Noa Ben   Biran Haim   Man Sofia   Shani Adi  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 324-329

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

By Hainsworth John   Yardley Denise   Spigel David   Meluch Anthony   Rinaldi David   Schnell Frederick   Greco F.  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 469-473

Informa Healthcare

Access to resources Recommend Favorite

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study

By Santini Daniele   Massacesi Cristian   D’Angelillo Rolando   Marcucci Fabiana   Campisi Costantino   Vincenzi Bruno   Pilone Alberta   Bianco Vincenzo   Bonsignori Maurizio   Tonini Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 59-66

Humana Press, Inc

Access to resources Recommend Favorite